Alejandro Martínez‐Bueno

Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial

José Manuel Pérez-García, Marta Vaz Batista, Patricia Cortez et al. · Neuro-Oncology · 2022 · 248 citations · Full text

Medicine, Oncology, Pharmacology +17

Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients

Umberto Malapelle, Clara Mayo de-las-Casas, Danilo Rocco et al. · British Journal of Cancer · 2017 · 140 citations · Full text

Medicine, Genetics, Oncology +17

Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions

Clara Mayo‐de‐las‐Casas, Núria Jordana‐Ariza, Mónica Garzón‐Ibáñez et al. · Annals of Oncology · 2017 · 98 citations · Full text

Medicine, Genetics, Oncology +13

Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions

Sergi Villatoro, Clara Mayo‐de‐las‐Casas, Núria Jordana‐Ariza et al. · Molecular Oncology · 2019 · 84 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Beyond liquid crystals: new research trends for mesogenic molecules in liquids

Martín Castillo‐Vallés, Alejandro Martínez‐Bueno, Raquel Giménez et al. · Journal of Materials Chemistry C · 2019 · 51 citations

Natural Sciences, Chemistry, Materials Science +15